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Abstract
Background: The development of occupational asthma is the result of interactions between environmental factors and
individual susceptibility. We assessed how our model of chemical-induced asthma is influenced by using different mouse
strains.
Methodology/Principal Findings: On days 1 and 8, male mice of 7 different strains (BALB/c, BP/2, A/J, C57Bl/6, DBA/2, CBA
and AKR) were dermally treated with toluene-2,4-diisocyanate (TDI) (0.3%) or vehicle (acetone/olive oil, AOO, 2:3) on each
ear (20 ml). On day 15, they received an oropharyngeal instillation of TDI (0.01%) or AOO (1:4). Airway reactivity to
methacholine, total and differential cell counts in bronchoalveolar lavage (BAL) and total serum IgE and IgG2a levels were
measured. Lymphocyte subpopulations in auricular lymph nodes and in vitro release of cytokines by ConA stimulated
lymphocytes were assessed. In TDI-sensitized and challenged mice, airway hyper-reactivity was only observed in BALB/c, BP/
2, A/J and AKR mice; airway inflammation was most pronounced in BALB/c mice; numbers of T-helper (CD4
+), T-activated
(CD4
+CD25
+), T-cytotoxic (CD8
+) and B- lymphocytes (CD19
+) were increased in the auricular lymph nodes of BALB/c, BP/2,
A/J and CBA mice; elevated concentrations of IL-4, IL-10, IL-13 and IFN-c were detected in supernatant of lymphocytes from
BALB/c, BP/2, A/J, C57Bl/6 and CBA mice cultured with concanavaline A, along with an increase in total serum IgE.
Conclusion: The used mouse strain has considerable and variable impacts on different aspects of the asthma phenotype.
The human phenotypical characteristics of chemically-induced occupational asthma were best reproduced in Th2-biased
mice and in particular in BALB/c mice.
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Introduction
Asthma is a chronic inflammatory airway disease that has
emerged as a major health concern among industrialized nations
[1]. In adult asthma, occupational exposures are estimated to be
responsible for 10% to 25% of the asthma prevalence [2].
Occupational asthma has become the most common work-related
lung disease.
Diisocyanates, used in the production of polyurethanes and one
of the leading causes of occupational asthma worldwide, are highly
reactive low molecular weight chemicals with significant sensitiz-
ing potential [3,4].
Although exposed to similar allergic stimuli, not all humans
develop allergic or occupational asthma. The etiology of asthma is
complex and is associated with a combination of immune, genetic,
environmental and socio-economic factors [1,5].
The mouse genome has been extensively characterized and
exhibits a high degree of homology with its human counterpart.
Especially, a high level of resemblance at the immunological level
has been found, suggesting that mouse models can yield a relevant
insight into human pathology [6]. Maximum genetic uniformity
can be achieved when using inbred strains. Environmental factors
such as exposure to light, diet, air quality and climate can
influence the phenotypic outcome of asthma. The advantage of
using an animal model is that these confounding factors can be
largely controlled in laboratory animal housing situations [5,7].
Using different inbred strains of mice gives the opportunity to
estimate the influence of the genetic background on the
phenotypical outcome of chemical-induced asthma.
Starting from an established mouse model of chemical-induced
asthma developed by Vanoirbeek et al. in BALB/c mice, 6 other
inbred mouse strains were tested on their sensitizing capacity to
toluene-2,4-diisocyanate (TDI) [8–12]. Three of the selected
mouse strains are Th2-biased (BALB/c, BP2 and A/J), while the
others were Th1-biased strains (C57Bl/6, DBA/2, AKR and
CBA). By testing different mouse strains we have the opportunity
to evaluate the intra- (experimental) and the inter-strain
variability, giving us the possibility to select the inbred mouse
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12581strain which represents best the phenotype of human occupational
asthma.
Materials and Methods
Ethics statement
All experimental procedures were approved by the local Ethical
Committee for Animal Experimentation of the K.U.Leuven
(project license number 072/2009). The research projects that
are approved by the local Ethical Committee for Animal
Experimentation of the K.U.Leuven are in accordance with the
Belgian and European laws, guidelines and policies for animal
experimentation, housing and care. This means that they are in
accordance with the Belgian Royal Decree of 14 November 1993
concerning the protection of laboratory animals and the European
Directive 86-609-EEC. The animals are housed – according to the
Belgian and European laws, guidelines and policies for animal
experiments, housing and care - in the Central Animal Facilities of
the university. These facilities have the obligatory accreditation of
the authorized Belgian Ministry and are registered under license
number LA2210393. All efforts were made to minimize suffering.
Reagents
Toluene-2,4-diisocyanate (98%, CAS 584-84-9) (MW: 174.15),
acetyl-b-methylcholine (methacholine), acetone and diethyl ether
were obtained from Sigma-Aldrich (Bornem, Belgium). Isoflurane
(ForeneH) was obtained from Abbott Laboratories (S.A. Abbott
N.V., Ottignies, Belgium) and Pentobarbital (NembutalH) from
Sanofi Sante ´ Animale (CEVA, Brussels, Belgium). For dermal
applications, the vehicle (AOO) consisted of 2 volumes of acetone
(A) and 3 volumes of olive oil (OO) (Selection de Almazara,
Carbonell, Madrid, Spain). For the oropharygeal aspiration the
vehicle (AOO) consisted of a mixture of 1 volume of acetone and 4
volumes of olive oil. AOO is one of the standard vehicles for the
local lymph node assay (OECD 2002, guideline 429) and it has
been proven to be an ideal vehicle for non-aqueous compounds
like TDI. In previous experiments we optimized the proportions of
A and OO for dermal sensitization and challenge to avoid
irritation, inflammation or airway response, in the control group
[8,12]. Concentrations of TDI are given as percent (v/v) in AOO.
Animals
Male BALB/c OlaHsd, A/J OlaHsd, C57Bl/6J OlaHsd, AKR
OlaHsd, DBA/2 OlaHsd and CBA/J CrHsd mice (6 weeks old)
were obtained from Harlan (Horst, The Netherlands), while male
BP/2IcRj-Biozzi mice were purchased from Janvier (Le Genest
Saint Isle, France). The mice were housed in a conventional
animal house with 12-h dark/light cycles. They were housed in
filter top cages and received lightly acidified water and pelleted
food (Trouw Nutrition, Gent, Belgium) ad libitum.
Groups of animals and treatment protocol
As previously described, on days 1 and 8, the animals received a
dermal application (20 ml) of 0.3% TDI or vehicle (AOO, 2:3) on
the dorsum of both ears. On day 15, they received, under light
isoflurane anesthesia, an oropharyngeal aspiration (20 ml) of
0.01% TDI (challenge) or vehicle (AOO, 1:4) [12]. Mice were
sacrificed 24 hours after the last challenge. Each group consisted
of 6–14 animals. Experimental groups are 0/0, 0/1 and 1/1. The
first digit identifies the agent used for the dermal application on
days 1 and 8 (sensitization) and the second digit identifies the agent
administered via oropharyngeal aspiration on day 15 (challenge).
Treatment with TDI is indicated as 1 and treatment with vehicle is
indicated as 0. Thus, the 1/1 group, for example, consists of mice
that received dermal applications of TDI (days 1 and 8, first digit)
and an oropharyngeal challenge of TDI (day 15, second digit). All
treatments and procedures were performed each time around the
same hour of the day and the different experimental groups (0/0,
0/1 and 1/1) were mixed within each mouse strain. Different
strains were performed in succession.
Airway hyper-reactivity (AHR)
Airway hyper-reactivity was measured 24 h after the oropha-
ryngeal challenge, using a forced oscillation technique (FlexiVent,
SCIREQ, Montreal, Canada). As previously described, mice were
anesthetized with pentobarbital (70 mg/kg body weight) and
airway resistance (R) to increasing concentrations of methacholine
(from 0 to 10 mg/ml) was measured using a ‘‘snapshot’’ protocol.
For each mouse, R was plotted against methacholine concentra-
tion (from 0 to 10 mg/ml) and the area under the R-methacholine
concentration curve (AUC) was calculated [13].
Pulmonary inflammation (bronchoalveolar lavage)
After the functional airway measurements (1 day after
challenge), mice were deeply anesthetized by an intraperitoneal
injection of pentobarbital (90 mg/kg body weight). For later
measurements of total serum immunoglobulins, blood was first
sampled from the retro-orbital plexus, and the mice were then
killed by section of the abdominal vessels. Serum samples,
obtained after centrifugation (14,000 g, 10 min) of whole blood,
were stored at 280uC until analysis. The lungs were lavaged, in
situ, three times with 1 ml sterile saline (0.9% NaCl) and kept on
ice. The recovered fluid of the first lavage was kept separately,
while the two subsequent lavages were pooled. The first lavage was
centrifuged (1000 g, 4uC, 10 min) and the supernatant was frozen
(280uC) for further analyses of cytokines, while the pellet was
resuspended with 0.9% NaCl to match the original volume.
Subsequently, all three lavages were pooled and the cells were
counted using a Bu ¨rker hemocytometer (total cell count) to assess
airway inflammation. For differential cell counts, cells were spun
(300 g, 6 min) (Cytospin 3, Shandon, TechGen, Zellik, Belgium)
onto microscope slides, air-dried and stained (Diff-QuikH method,
Medical Diagnostics, Du ¨dingen, Germany). For each sample, 200
cells were counted for the number of macrophages, eosinophils,
neutrophils and lymphocytes.
Levels of IL-2, IL-5, IL-6, IL-13, tumor necrosis factor-alpha
(TNF-a), and cytokine-induced neutrophils chemoattractant (KC)
were measured in undiluted BAL fluid (first fraction) by
Cytometric Bead Array and were analyzed with FCAP Array
Software on the FACSArray (BD Bioscience, Erembodegem,
Belgium). Lower limits of detection were 0.2 pg/ml, 0.9 pg/ml,
1.4 pg/ml, 1.4 pg/ml, 0.8 pg/ml and 2.4 pg/ml, respectively.
Lymph node cells analysis
To characterize the different subpopulations of lymphocytes
and to measure cytokines in the supernatant of cultured
lymphocytes, retro-auricular lymph nodes were obtained from
the same mice and were processed for each mouse separately,
except when there were not enough cells present to perform FACS
analyses and cell culture in which case lymph nodes of different
mice were pooled. The lymph nodes were kept on ice in RPMI-
1640 (Invitrogen, Merelbeke, Belgium) and cell suspensions were
obtained by pressing the lymph nodes through a cell strainer
(100 mm) (BD Bioscience, Erembodegem, Belgium) and rinsing
with 10 ml tissue culture medium (RPMI-1640). Cells were
counted using a Bu ¨rker hemocytometer. Lymphocytes were
washed three times and suspended (10
7 cells/ml) in complete
tissue culture medium (RPMI-1640 supplemented with 10% heat-
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IU/ml penicillin). Five-hundred thousand cells were stained with
anti-CD3
+ (APC, T-lymphocytes), anti-CD4
+ (APC-Cy7, Th-
lymphocytes), anti-CD8
+ (PerCP-Cy5.5, Tc-lymphocytes) and
anti-CD25
+ (PE, activated/regulatory T-lymphocytes), or received
a single staining with anti-CD19
+ (PE, B-lymphocytes) labeled
antibodies, according to standard procedures, and with control
samples being labeled with isotype match control antibodies (BD
Biosciences, Erembodegem, Belgium). Flow cytometry (FACSAr-
ray, BD Biosciences, Erembodegem, Belgium) was performed
using at least 10
5 cells.
Cells were seeded into 48-well culture plates at a density of 10
6
cells/ml and incubated in complete RPMI-1640 medium for 42 h
with 2.5 mg/ml of concanavaline A (ConA) (Sigma–Aldrich,
Bornem, Belgium). Cells were centrifuged (1000 g, 4uC, 10 min)
and supernatants were stored at 280uC. Levels of IL-2, IL-4, IL-10,
IL-13, IL-17 and interferon gamma (IFN-c) were measured via
Cytometric Bead Array and analyzed with the FCAP Array
Software on the FACSArray (BD Biosciences, Erembodegem,
Belgium). Lower detection limits were 0.2 pg/ml, 0.3 pg/ml,
9.6 pg/ml, 2.4 pg/ml and 0.95 pg/ml and 0.5 pg/ml, respectively.
Total serum IgE and IgG2a
The OptEIA
TM Mouse IgE and IgG2a set from Pharmingen
(BD Biosciences, Erembodegem, Belgium) were used to measure
total serum IgE (diluted 1/70) and total serum IgG2a (diluted 1/
10,000). Measurements were performed according to the manu-
facturer’s instructions.
Data analysis
A normal distribution of the data was assessed by the
D’Agostino & Pearson omnibus normality test. All data are
presented as means and standard deviations (S.D.), except for the
AUC data of the AHR, which is shown as individual data and
group means. The concentrations of cytokines in BAL and
supernatant, as well as the lymph node subpopulations and IgE
and IgG2a were analyzed with a one-way ANOVA test followed by
a Bonferroni’s multiple comparison test. According to the
D’Agostino & Pearson omnibus normality test, the AUC data of
the AHR and the differential cell counts were not normally
distributed and therefore were analyzed with a non-parametric
Kruskal–Wallis test followed by a Dunn’s multiple comparison test
(Graphpad Prism 4.01, Graphpad Software Inc, San Diego, USA).
A level of p,0.05 (two-tailed) was considered significant.
Results
Figure 1 shows the results of airway reactivity to methacholine
24 hours after the challenge with TDI or vehicle. Figures 1A to 1G
show the airway resistance (R) after increasing concentrations of
Figure 1. Airway hyperresponsiveness (AHR) in different mouse strains. The airway resistance (R), after increasing concentrations of
methacholine (0–10 mg/ml), was measured 24 hours after the challenge. Figures A) to G) reflect the airway hyperresponsiveness to increasing
concentrations of methacholine per mouse strain. Figure H) represents the AUC of R per experimental condition and per mouse strain. Experimental
groups are 0/0, 0/1 and 1/1. The first number identifies the agent used for the dermal applications (sensitizations) and the second number identifies
the agent used for the oropharyngeal aspiration (challenge). A treatment with toluene-2,4-diisocyanate (TDI) is shown as 1 and a treatment with the
vehicle (a mixture of acetone and olive oil), is shown as 0. Data are presented as mean 6 S.D. (A–G) and mean with individual values (H), n=5–11 per
group, * p,0.05, ** p,0.01 and *** p,0.001 compared with the 0/0 group, # p,0.05 and ### p,0.001 compared with the 0/1 group.
doi:10.1371/journal.pone.0012581.g001
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figure 1H shows the AUC of the R against methacholine
concentration. Significant differences between the TDI-treated
and vehicle-treated animals were found in all the Th2-biased
strains (BALB/c, BP2 and A/J) and also in one of the Th1-biased
strains (AKR). BALB/c mice exhibited the most pronounced
difference between the 1/1 group and the two control groups.
The numbers of macrophages, neutrophils and eosinophils in
BAL fluid, 24 hours after challenge, are is shown in figures 2A and
2B. BALB/c mice exhibited significant increases in neutrophils (6-
fold) and eosinophils (1.3-fold) after sensitization and challenge
with TDI compared to the 0/0 group. Among the Th-1 biased
animals, the AKR mice also exhibited significant increases in
neutrophil and eosinophil numbers.
The cytokines IL-2, IL-5, IL-6, IL-13, TNF-a and KC were
assessed in the BAL fluid (data not shown). In none of the mouse
strains were there any significant differences between the 1/1
groups and their respective control groups (0/0, 0/1).
Lymphocyte subpopulations were characterized in auricular
lymph nodes, 24 hours after the challenge (figure 3). All the Th2-
biased strains (BALB/c, BP2 and A/J) exhibited a significantly
higher amount of Th-lymphocytes (CD3
+CD4
+, figure 3A),
activated/Treg-lymphocytes (CD3
+CD4
+CD25
+, figure 3B), Tc-
lymphocytes (CD3
+CD8
+, figure 3C) and B-lymphocytes (CD19
+,
figure 3D) in TDI sensitized and challenged animals compared to
their control groups. Among the Th1-biased strains, significant
differences in Treg-, Tc- and B-lymphocytes were found in CBA
mice, and AKR mice showed significantly higher amounts of Th-
and B-lymphocytes in the 1/1 group compared to the controls.
Table 1 gives an overview of the different cytokines measured in
the supernatants of auricular lymphocytes cultured in the presence
of ConA. IL-2 and IL-17 gave no significant differences in any of
Figure 2. Differential cell count in BAL in different mouse strains. The number of macrophages, neutrophils and eosinophils was counted in
the BAL fluid. Figure A) represents the differential cell count in the Th2-biased mouse strains and figure B) the differential cell count in the Th1-biased
mouse strains. Experimental groups are identical to figure 1. Data are presented as means 6 S.D., n=6214 per group, * p,0.05 and ** p,0.01
compared to the 0/0 group, # p,0.05 and # p,0.01 compared to the 0/1 group.
doi:10.1371/journal.pone.0012581.g002
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of the C57Bl/6 compared to the 0/0 group (data not shown). IL-4
levels are significantly higher in the 1/1 groups of all mouse
strains, except in C57Bl/6 mice. Increased concentrations of IL-10
were found for BALB/c, BP2, A/J, DBA/2 and AKR mice,
whereas IL-13 was increased in all Th2-biased mice and in AKR
mice. Concentrations of IFN-c were significantly increased in
BALB/c, BP2 and A/J mice.
Total serum IgE levels (figure 4) were significantly higher
compared to their two control groups (0/0, 0/1) in all mouse
strains, except DBA/2 mice. No differences were found for total
serum IgG2a levels (data not shown).
Discussion
Seven mouse strains were tested in an established mouse model
of chemical-induced asthma [8–12]. The main findings of this
study were that, in general, Th2-biased mice reproduce better
than Th1-biased mice, the features that characterize human
occupational asthma. BALB/c mice showed the most pronounced
differences in AHR, airway inflammation and immunologic
parameters, when compared to the two other Th2-biased mouse
strains tested (BP2 and A/J). Th1-biased mice, however, were not
completely non-responsive.
Mice are the most commonly used species to develop
experimental models of human diseases. Mice are easy to breed,
economical to house and relatively easy to work with. Further-
more, the mouse genome has been extensively studied and it
exhibits a high degree of homology with the human genome.
Further advantages are the wide variety of available immu-
nological and molecular reagents as well as transgenic animals
[6,14].
Besides the many advantages of animal models, there is still a lot
of controversy concerning the use of animals to study human
disease. Thus, mice do not spontaneously exhibit symptoms
consistent with asthma. Different treatment protocols have been
developed to mimic the phenotypes of human asthma, but no
mouse model is currently able to mimic the full range of clinical
manifestations. Furthermore, important differences exist in airway
development and morphology between humans and mice. Mouse
airways have fewer airway generations and do not contain smooth
muscle bundles. Nevertheless, although mice cannot be considered
as perfect surrogates for humans, they can be used to test
hypotheses in a relatively simple controlled system [6,15,16].
Figure 3. Lymphocyte subpopulations in the auricular lymph nodes of different mouse strains. Auricular lymph nodes were collected
and FACS analyses were performed. A) CD3
+CD4
+ (Th-lymphocytes), B) CD3
+CD4
+CD25
+ (activated/Treg-lymphocytes), C) CD3
+CD8
+ (Tc-
lymphocytes) and D) CD19
+ (B-lymphocytes) lymphocytes were characterized. Experimental groups are the same as in figure 1. Data are presented as
means 6 S.D., n=429, * p,0.05, ** p,0.01 and *** p,0.001 compared to the 0/0 group, # p,0.05, ## p,0.01 and ### p,0.001 compared to
the 0/1 group.
doi:10.1371/journal.pone.0012581.g003
Table 1. Cytokines in supernatants of lymphocytes obtained from auricular lymph nodes.
IL-4 IL-10 IL-13 IFN-c
BALB/c 0/0 1.360.3 29.9612,0 8.164,0 103641
0/1 0.960.1 22.4620,0 8.7611,0 124.1668,0
1/1 10.167,0
(*, ##) 110642
(**, ##) 162658
(***, ###) 4576188
(**, ##)
BP2 0/0 0.260.6 5.668,0 10.8614,0 441.16668,0
0/1 0.260.2 3.763,0 7.364,0 3906314
1/1 462
(***, ###) 46.6632
(**,##) 5306249
(***,###) 225161316
(**, ##)
A/J 0/0 0.360.4 3.164,0 4.164,0 123.5615,0
0/1 0.460.2 4.262,0 362 86.7659,0
1/1 8.263
(***, ###) 77.3669,0
(*) 2266159
(*, #) 8096542*
C57Bl/6 0/0 1.461,0 49.5661,0 90.36120,0 78.4694,0
0/1 0.660.5 16.3614,0 45.4647,0 170.56290,0
1/1 1.461,0 46.2640,0 106.7686,0 296.56511,0
DBA/2 0/0 0.860.3 13.967,0 14.7610,0 433.26174,0
0/1 1.360.5 28.4617,0 28.6620,0 470.66226,0
1/1 5.262,0
(**, ##) 46.7619,0
(**) 59.4639,0 7556428
CBA 0/0 1.360.5 15.568,0 1669 985.86438,0
0/1 0.560.1 3.162,0 262 142.26110,0
1/1 7.962
(***, ###) 63.5620,0
(##) 184.1662,0
(###) 836.76231,0
AKR 0/0 0.660.2 54.8628,0 56.7636,0 31246683
0/1 0.660.2 46.7629,0 54.6622,0 32866373
1/1 2.462,0
(*, #) 115.3651
(*, #) 231693
(**, ##) 33836104
Auricular lymph node cells were cultured (42 h) with concanavaline A (2.5 mg/ml). Concentrations (pg/ml) of IL-2 (data not shown), IL-4, IL-10, IL-13, IL-17 (data not
shown) and IFN-c were measured, by Cytometric Bead Array, in the supernatant. Experimental groups are identical to those in figure 1. Data are presented as mean 6
S.D., n=4211 values per group. * p,0.05, ** p,0.01 and *** p,0.001 compared to the 0/0 group and
# p,0.05,
## p,0.01 and
### p,0.001 compared to the 0/1
group.
doi:10.1371/journal.pone.0012581.t001
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standardize techniques and protocols used, to be able to compare
the results of different research groups. So far, the influence of the
genetic background of mice on ventilatory and immunological
parameters has not been studied much. Our study is one of the
first to have compared multiple endpoints of immune-mediated
asthma in a large number of inbred mouse strains. It is surprising
how little is known about genetic differences between the
commercially available inbred mouse strains, which makes it hard
to link phenotypic differences in parameters to genetic variability.
So far, our ventilatory, inflammatory and immunologic results can
only be linked to a predominant Th1- or Th2-bias.
Clear differences were found in airway hyper-reactivity to
methacholine in the different mouse strains. Th2-biased mouse
strains showed increases in airway hyper-reactivity compared to
Th1-biased mice, as already shown by different other research
groups in other asthma models [1,17–20]. However, one exception
is the AKR strain, which although being Th1-biased, responded
significantly in terms of increase in airway hyper-reactivity [21].
Furthermore, we found differences in baseline reactivity to
methacholine between the different Th2-biased mice. BP2 and
A/J mice were found to be more sensitive to methacholine
provocation than BALB/c mice and this both for the TDI-treated
animals and the control mice. Among the three Th2-biased
strains, the BALB/c mice presented the best separation between
TDI-sensitized plus TDI-challenged animals and the controls.
Differences in baseline airway hyper-reactivity can be an intrinsic
characteristic of the mouse strain. Differences in alveolar size, lung
volume, elastic properties and differences in controlling smooth
muscle cells by the autonomic nerve system have been described
[22–24].
When we analyse our results of the airway hyper-reactivity more
in detail, we can conclude that individual adjustments for
methacholine concentrations per mouse strain are preferable. A/
J mice reach a plateau at 10 mg/ml methacholine (figure 1C),
while C57Bl/6 mice are still at a submaximum at that
concentration (figure 1D). We chose to perform the methacholine
provocation with the same methacholine concentrations for each
mouse strain to make comparisons easier.
In our model, airway inflammation in TDI-induced asthma is
characterized by an influx of mainly neutrophils and also some
eosinophils [10,12,25]. This study showed that BALB/c mice have
the most pronounced airway inflammation of all 7 mouse strains.
However, our observations support that there is no consistent
relationship between airway hyper-reactivity and the influx of
neutrophils and eosinophils in the lungs, as already shown by
Whitehead et al. [26]. When using ovalbumin models, C57Bl/6
are often used and they respond with a robust airway eosinophilic
response [19,27]. It is conceivable, as suggested by Herrick et al.,
that the ability to generate airway inflammation after chemical
exposure is under different and perhaps tighter genetic control
than the ability to mount these responses after exposure to other
antigens [27].
Significant increases in the total amount of Th-, Treg-, Tc- and
B-lymphocytes were found in all Th2-biased mouse strains and for
some lymphocyte subpopulations also for the Th1-biased CBA
and AKR mice. Vogelsang et al. already showed that there are
different amounts of conventional and plasmacytoid dendritic cells
and Treg-lymphocytes in blood and spleen of BALB/c vs. C57Bl/
10J mice [28]. This confirms that the genetic background of the
mouse strain plays a role in the development of different
immunologically linked cell subtypes and probably also in their
cytokine production.
Increases in IL-4 were associated with increases in the total
amount of B-lymphocytes and with proportional increases in total
serum IgE. However, BALB/c mice turned out to be limited
producers of total serum IgE compared to the other mouse strains
tested. This raises again the question of the relevance of IgE in
chemical-induced asthma. For many low molecular weight
compounds, specific IgE antibodies have only been found in a
small subset of patients [29]. The presence of total IgE in serum
serves as a marker of prior sensitization in mice, but has limited
functional consequences. This confirms the hypothesis of a non-
IgE mediated cellular mechanism involved in the development of
chemical-induced asthma. In our data the amount of IL-4 does not
always correlate with the level of IgE present in the serum. IL-4
plays an important role in the production of IgE, but mediates also
other pathways such as the differentiation of Th-lymphocytes, the
ability to induce the expression of vascular cell adhesion molecule
1 (VCAM-1) and the production of mucus in the asthmatic airway
[30].
In an attempt to create a comprehensible overview of all the
results combined, we made a radar graph for each mouse strain
(figure 5). In the radar graphs the complete control group (0/0)
Figure 4. Total serum IgE in different mouse strains. Total serum IgE was measured 24 hours after the challenge. Experimental groups are the
same as in figure 1. Data are presented as means 6 SD, n=6–14, ** p,0.01 and *** p,0.001 compared to the 0/0 group, ## p,0.01 and ###
p,0.001 compared to the 0/1 group.
doi:10.1371/journal.pone.0012581.g004
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(red field). The radar graphs visualize pronounced differences
between Th2- and Th1-biased mouse strains. While BALB/c, BP2
and A/J mice gave high values in respiratory, inflammatory and
immunological parameters characteristic for occupational asthma,
C57Bl/6 and CBA mice showed hardly any responses in our
mouse model. In the context of ‘a mouse model of chemical-
induced asthma’ both the limited response of the 0/0 group in the
BALB/c mice, along with a pronounced response in the 1/1
group, makes the BALB/c mouse strain the most favorable to use,
at least in the short term. When we approach the results from a
different angle, we can also suggest that C57Bl/6 mice could be a
good mouse strain to investigate why most people do not develop
allergy and asthma, while some do. The radar graphs show also
that TDI sensitization yields a mixed Th1-Th2 profile, as
previously shown by us and other research groups, especially in
the Th2-biased mouse strains [10,12,25,31,32]. Therefore, in the
context of chemical-induced asthma, it is not correct to state that a
certain mouse strain is more Th2-biased than Th1-biased.
In conclusion, this study, based on a comparison of seven
different inbred mouse strains in a model of chemical-induced
asthma, demonstrates that the genetic background of the different
mouse strains has a large impact on the phenotypical outcome of
TDI-induced asthma. Caution has to be taken when comparing
results from different mouse strains. Furthermore, in this model,
BALB/c mice represented best the characteristics of chemical-
induced asthma.
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